At baseline and at weeks 8 and 12, a clinician should assess fasting insulin and HOMA-IR (the homeostasis model assessment of insulin resistance, a calculated index derived from fasting glucose and insulin), HbA1c, high-sensitivity C-reactive protein as an inflammatory marker, and body composition by DEXA scan or bioelectrical impedance
The lack of comprehensive safety information necessitates careful consideration and medical supervision for these exploring its use
For most people, expect about one to two weeks of noticeable effects, with the exact timing shaped by your levels, metabolism, diet, absorption, and age
Injectable forms offer direct bioavailability for systemic or localized effects, which is common in tissue repair models
While efficacy matters, the tolerability and adverse effect profile often determines whether a treatment is suitable for long-term use